Beyond the trigger: the unknown precipitant as a high-risk phenotype in acute heart failure
Jenseits des Auslösers: der unbekannte Auslöser als Hochrisiko-Phänotyp bei akuter Herzinsuffizienz
Frontiers in Cardiovascular Medicine · 30.10.2026 · 13
DOI: 10.3389/fcvm.2026.1880740 ↗Auf einen Blick
Bei 486 Patient:innen mit akuter Herzinsuffizienz war ein unbekannter Auslöser mit höherer 12-Monats-Mortalität und ungünstigerem Verlauf verbunden. Nach Adjustierung war der Zusammenhang abgeschwächt.
Fragestellung
Unterscheiden sich klinisches Profil, echokardiografische Merkmale und mittelfristige Outcomes bei AHF je nach Kategorie des auslösenden Faktors?
Methode
Prospektive monozentrische Beobachtungsstudie mit 486 konsekutiven Patient:innen in Heraklion; Vergleich von 3 Gruppen mittels Kaplan-Meier und Cox-Regression.
Ergebnisse
Die unbekannte Gruppe zeigte 12-Monats-Mortalität von 41,7 % vs. 20,3 % und 29,6 %; unkown vs. behavioral HR 2,44 (95 %-KI 1,54–3,88). Für das Composite: HR 1,96 (1,39–2,77).
Schlussfolgerung der Autor:innen
Bei AHF kennzeichnet das Fehlen eines identifizierbaren auslösenden Faktors einen Hochrisiko-Phänotyp mit schwerer Multimorbidität, rechtsventrikulärer Dysfunktion, Nierenfunktionsstörung und schlechteren mittelfristigen Outcomes.
Kernaussagen
- Unbekannter Auslöser: 12-Monats-Mortalität 41,7 %
- Unadjustiert höheres Risiko: HR 2,44 (95 %-KI 1,54–3,88)
- Nach Adjustierung war der Zusammenhang mit Mortalität nicht mehr signifikant
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 30.10.2026. Verfasst von Georgios Aletras und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Venizelio General Hospital of Heraklion, Heraklion, Greece. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
A substantial proportion of patients with acute heart failure (AHF) present without an identifiable precipitating factor. We compared the clinical profile, echocardiographic characteristics, and mid-term outcomes of AHF patients stratified by precipitating factor category.
Methods
We conducted a prospective single-center observational study at Venizelio General Hospital, Heraklion, including 486 consecutive patients hospitalized with AHF between February 2023 and January 2025. Patients were classified into three groups: behavioral ( n = 148), non-behavioral/clinical ( n = 230), and unknown ( n = 108). The primary endpoint was all-cause death at 12 months; secondary endpoints were terminal renal replacement therapy (RRT) and a composite of death, AHF rehospitalization or RRT. Groups were compared by Kaplan–Meier analysis and Cox regression with the behavioral group as reference, and the cumulative incidence of first AHF rehospitalization was estimated with death and terminal RRT as competing events.
Results
The unknown group was older and more frail (CFS ≥5), with more advanced chronic kidney disease, more right heart failure and lower TAPSE, higher NT-proBNP and lower admission eGFR. All-cause mortality at 12 months was 41.7% versus 20.3% and 29.6% (log-rank p < 0.001; unknown vs. behavioral HR 2.44, 95% CI 1.54–3.88), with a parallel gradient for the composite endpoint (event-free survival 35.2% vs. 58.8% and 52.6%; HR 1.96, 1.39–2.77). After adjustment for age, admission eGFR, right heart failure, NT-proBNP and frailty, precipitant category no longer improved model fit (likelihood ratio p = 0.066) and the association of the unknown group with mortality was attenuated and no longer significant (adjusted HR 1.43, 0.88–2.31). With death and terminal RRT as competing events, 12-month cumulative incidence of first AHF rehospitalization did not differ (36.1% vs. 29.7% and 26.1%; p = 0.207). ACEi/ARB prescription at discharge was lower in the unknown group (21.2% vs. 39.0% and 44.2%, p < 0.001).
Conclusions
In AHF, the absence of an identifiable precipitating factor identifies a high-risk phenotype characterized by advanced multimorbidity, right ventricular dysfunction, renal impairment and worse mid-term outcomes. The difference was driven predominantly by mortality rather than rehospitalization, and the association was attenuated after adjustment for the phenotype-defining variables. The label may therefore serve as an early bedside marker of advanced disease, requiring confirmation in multicenter cohorts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Venizelio General Hospital of Heraklion, Heraklion, Greece.
- School of Medicine, University of Crete, Heraklion, Greece.
- Second Department of Internal Medicine, Venizelio General Hospital of Heraklion, Heraklion, Greece.
- Institution of Applied and Computational Mathematics, Foundation of Research and Technology-Hellas, Heraklion, Greece.
- Department of Cardiology, University General Hospital of Heraklion, Heraklion, Greece.
- Department of Nephrology, University General Hospital of Heraklion, Heraklion, Greece.
Zitieren
APA
Aletras, G., Bachlitzanaki, M., Stratinaki, M., Lamprogiannakis, E., Foukarakis, E., Pantazis, Y., Hamilos, M., & Stylianou, K. (2026). Beyond the trigger: the unknown precipitant as a high-risk phenotype in acute heart failure. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1880740
Vancouver
Aletras G, Bachlitzanaki M, Stratinaki M, Lamprogiannakis E, Foukarakis E, Pantazis Y, et al. Beyond the trigger: the unknown precipitant as a high-risk phenotype in acute heart failure. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1880740
BibTeX
@article{Aletras2026,
author = {Aletras, Georgios and Bachlitzanaki, Maria and Stratinaki, Maria and Lamprogiannakis, Emmanuel and Foukarakis, Emmanuel and Pantazis, Yannis and Hamilos, Michalis and Stylianou, Kostas},
title = {Beyond the trigger: the unknown precipitant as a high-risk phenotype in acute heart failure},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1880740}
}
EUVIMED